文献速递乳腺乳腺X线

筛查检出恶性肿瘤在全视野数字乳腺X线摄影与合成乳腺X线摄影上的可见度比较

Conspicuity of Screen-Detected Malignancies on Full Field Digital Mammography vs. Synthetic Mammography.
PubMed 文献 · Acad Radiol · 2019-07-12

本研究回顾性纳入2015年10月1日至2017年6月30日连续筛查检出的乳腺癌181例,由三名放射科医师共识评分比较合成乳腺X线摄影(SM)与全视野数字乳腺X线摄影(FFDM)的可见度。多数病灶在SM上等于或更可见(76%,137/181),但钙化和大于2cm的结构扭曲在SM上更可见,不对称在SM上较FFDM不 visible。结论提示以SM+DBT替代FFDM+DBT筛查时,评估单视图不对称和小于2cm病灶需谨慎。

要点

  • 多数筛查检出癌在SM上等于或更可见(76%,137/181),但钙化和大于2cm的结构扭曲在SM上更可见。
  • 不对称在SM上较FFDM不 visible,评估单视图不对称时需谨慎。
  • 小于2cm的病灶在SM上较FFDM不 visible,阅片时需注意。

核心结论

  • 多数筛查检出癌在SM上等于或更可见,但钙化和大于2cm的结构扭曲在SM上更可见,不对称和小于2cm的病灶在SM上较FFDM不 visible;以SM+DBT替代FFDM+DBT筛查时,评估单视图不对称和小于2cm病灶需谨慎。

研究设计与样本

  • 经IRB批准的回顾性研究,连续纳入2015年10月1日至2017年6月30日筛查检出的癌症,由三名放射科医师共识评分(n=224),排除仅DBT可见(n=40)、无病史(n=2)和仅有皮肤增厚(n=1)的病例后,最终研究人群181例。

关键影像表现/征象

  • SM上乳腺X线特征:钙化68例(37.8%)、肿块51例(27.8%)、不对称50例(27.6%,其中局灶性不对称11例)、结构扭曲12例(6.8%)。
  • 多数病灶(76%,137/181)在SM上等于或更可见。
  • 控制绝经状态、乳腺癌家族史或个人史、BRCA状态和乳腺密度后,钙化和大于2cm的结构扭曲在SM上更可见。
  • 控制相同因素后,不对称在SM上较FFDM不 visible。

诊断标准与关键数值

  • 可见度评分:1=FFDM比SM更可见,2=FFDM与SM相当,3=SM比FFDM更可见。
  • 多数病灶(76%,137/181)在SM上等于或更可见。

临床应用与阅片要点

  • 以SM+DBT替代FFDM+DBT筛查时,评估单视图不对称和小于2cm的病灶需谨慎。
  • 钙化和大于2cm的结构扭曲在SM上更可见。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate conspicuity of screen-detected cancers on two-dimensional synthetic mammography (SM) reconstructed from digital breast tomosynthesis (DBT) compared to two-dimensional full field digital mammography (FFDM).

MATERIALS AND METHODS: IRB-approved retrospective review of consecutive screen-detected cancers from October 1, 2015 to June 30, 2017 was performed. All examinations were reviewed by three radiologists in consensus (n = 224); a score of 1-3 was given to each screen-detected cancer on SM vs. FFDM [1 = FFDM more conspicuous than SM, 2 = FFDM equivalent to SM, and 3 = SM more conspicuous than FFDM]. Findings considered only visible on tomosynthesis (n = 40), without medical history (n = 2), and with skin thickening only (n = 1) were excluded, leaving 181 cases as the study population. The longitudinal medical record was reviewed to determine patient demographics and outcomes of imaging surveillance and biopsy.

RESULTS: Mammographic features on SM (n = 181) were calcifications (n = 68, 37.8%), masses (n = 51, 27.8%), asymmetries (n = 50, 27.6% [11 focal asymmetries]), and distortion (n = 12, 6.8%). The majority (76%, 137/181) of findings were equal or more conspicuous on SM vs. FFDM. However, calcifications and distortion greater than 2 cm were more conspicuous on SM and asymmetries were less conspicuous on SM vs. FFDM, controlling for menopausal status, family or personal history of breast cancer, BRCA status, and breast density.

CONCLUSION: Although the majority of screen-detected cancers are equal to more conspicuous on SM when compared to FFDM, calcifications and asymmetries <2cm were less conspicuous on SM than FFDM. When SM + DBT is used as an alternative to FFDM + DBT in breast cancer screening, caution should be taken when assessing one-view asymmetries and findings <2cm on SM.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Chikarmane SA, Yeh ED, Wang A, et al. Conspicuity of Screen-Detected Malignancies on Full Field Digital Mammography vs. Synthetic Mammography. Acad Radiol. 2019. PMID: 31307930. doi:10.1016/j.acra.2019.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。